Exact Mass: 372.134

Exact Mass Matches: 372.134

Found 142 metabolites which its exact mass value is equals to given mass value 372.134, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Syringin

(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-((E)-3-hydroxyprop-1-en-1-yl)-2,6-dimethoxyphenoxy)tetrahydro-2H-pyran-3,4,5-triol

C17H24O9 (372.142)

Syringin is a monosaccharide derivative that is trans-sinapyl alcohol attached to a beta-D-glucopyranosyl residue at position 1 via a glycosidic linkage. It has a role as a hepatoprotective agent and a plant metabolite. It is a beta-D-glucoside, a monosaccharide derivative, a primary alcohol and a dimethoxybenzene. It is functionally related to a trans-sinapyl alcohol. Syringin is a natural product found in Salacia chinensis, Codonopsis lanceolata, and other organisms with data available. See also: Codonopsis pilosula root (part of). A monosaccharide derivative that is trans-sinapyl alcohol attached to a beta-D-glucopyranosyl residue at position 1 via a glycosidic linkage. Syringin is a main bioactive phenolic glycoside in Acanthopanax senticosus, with anti-osteoporosis activity. Syringin prevents cardiac hypertrophy induced by pressure overload through the attenuation of autophagy[1][2]. Syringin is a main bioactive phenolic glycoside in Acanthopanax senticosus, with anti-osteoporosis activity. Syringin prevents cardiac hypertrophy induced by pressure overload through the attenuation of autophagy[1][2].

Citrusin E

Methyl 3-(3-methoxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)propanoic acid

C17H24O9 (372.142)

Citrusin E is found in citrus. Citrusin E is isolated from oil of lemon peel (Citrus limon). Isolated from oil of lemon peel (Citrus limon). Citrusin E is found in citrus.

(2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-[4-(3-hydroxyprop-1-enyl)-2,6-dimethoxyphenoxy]oxane-3,4,5-triol

C17H24O9 (372.142)

3-Pyridazinamine, N-(1-((3,4-difluorophenyl)methyl)-4-piperidinyl)-6-(trifluoromethyl)-

C17H17F5N4 (372.1373)

D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists

Multifidol glucoside

2-(2-Methylbutyryl)-phloroglucinol 1-O-beta-D-glucopyranoside

C17H24O9 (372.142)

A monosaccharide derivative that consists of multifidol attached to a beta-D-glucopyranosyl residue at position 1 via a glycosidic linkage. Isolated from Acacia mearnsii, it exhibits anti-inflammatory activity.

O-D-glycero-beta-L-manno-heptopyranosyl-(1<>2)-D-mannose|O-D-glycero-beta-L-manno-heptopyranosyl-(1[]2)-D-mannose

O-D-glycero-beta-L-manno-heptopyranosyl-(1<*>2)-D-mannose|O-D-glycero-beta-L-manno-heptopyranosyl-(1[*]2)-D-mannose

C13H24O12 (372.1268)

alpinoside

C17H24O9 (372.142)

14-acetoxygelsedilam

C19H20N2O6 (372.1321)

paeonin C

C17H24O9 (372.142)

1-[(pentanoyl)phloroglucinyl]-beta-D-glucopyranoside|1-[(Pentanoyl)phloroglucinyl]-??-D-glucopyranoside

C17H24O9 (372.142)

(12Z,15S,18S)-15-hydroxy-18-bromo-12,16,17-octadecatrienoic acid

C18H29BrO3 (372.13)

2-hydroxy-6-methoxyl-methylene-3-methyl-acetophenone-!-O-beta-D-glucopyranoside

C17H24O9 (372.142)

(-)-4-propionyl-2,6-dimethoxyphenyl beta-D-glucopyranoside|1-[4-(beta-D-glucopyranosyloxy)-3,5-dimethoxyphenyl]-1-propanone|4-(beta-D-glucopyranosyloxy)-3,5-dimethoxyphenyl-propanone

C17H24O9 (372.142)

Benzyl glycoside-beta-Pyranose-Xylobiose

C17H24O9 (372.142)

Me glycoside, benzyl ester-3-Deoxy-D-glycero-D-galacto-2-nonulosonic acid, 9CI

C17H24O9 (372.142)

methyl 2-O-beta-D-glucosyloxy-4-methoxybenzenepropanoate|Methyl 2-O-??-D-glucosyloxy-4-methoxybenzenepropanoate|methyl 3-(2-O-beta-D-glucopyranosyl-4-methoxyphenyl)propanoate

C17H24O9 (372.142)

paeonin A

C17H24O9 (372.142)

sinapyl glucoside

C17H24O9 (372.142)

Geniposidic acid

C17H24O9 (372.142)

grevilloside E methyl ester|methyl 5-(1,3-dihydroxyphenyl)butanoate 1-O-beta-D-glucopyranoside

C17H24O9 (372.142)

C17H24O9

C17H24O9 (372.142)

C18H25ClO6

C18H25ClO6 (372.134)

3,5-dimethyl-6-hydroxy-2-methoxy-4-O-D-glucopyranosyl-oxy-acetophenone

C17H24O9 (372.142)

alpha-Glc-(1->2)-L-glycero-D-glucoheptose

C13H24O12 (372.1268)

(13E,15R,18R)-15-hydroxy-18-bromo-13,16,17-octadecatrienoic acid

C18H29BrO3 (372.13)

1-[(3-methylbutanoyl)phloroglucinyl]-beta-D-glucopyranoside|1-[(3-methylbutyryl)phloroglucinyl]-beta-D-glucopyranoside|2-(3-methylbutyryl)phloroglucinol-1-O-beta-D-glucopyranoside|2-(3-methylbutyryl)phloroglucinol-beta-D-glucopyranoside|2-beta-D-glucopyranosyloxy-4,6-dihydroxyisovalerophenone|lysidiside A

1-[(3-methylbutanoyl)phloroglucinyl]-beta-D-glucopyranoside|1-[(3-methylbutyryl)phloroglucinyl]-beta-D-glucopyranoside|2-(3-methylbutyryl)phloroglucinol-1-O-beta-D-glucopyranoside|2-(3-methylbutyryl)phloroglucinol-beta-D-glucopyranoside|2-beta-D-glucopyranosyloxy-4,6-dihydroxyisovalerophenone|lysidiside A

C17H24O9 (372.142)

3-hydroxyl-2-methyl-4H-pyran-4-one-3-O-(6-isovaleryl)-beta-D-glucopyranoside

C17H24O9 (372.142)

TSC cpd

2,4,6,8,10,12,14-Hexadecaheptaenedioic acid, 2,6,11,15-tetramethyl-, sodium salt (1:2), (2E,4E,6E,8E,10E,12E,14E)-

C20H22Na2O4 (372.1313)

Trans Sodium Crocetinate is the sodium salt of the trans-isomer of the carotenoid crocetin with potential antihypoxic and radiosensitizing activities. Trans sodium crocetinate (TSC) increases the diffusion rate of oxygen in aqueous solutions such as from plasma to body tissue. The agent has been shown to increase available oxygen during hypoxic and ischemic conditions that may occur in hemorrhage, vascular and neurological disorders, and in the tumor microenvionment. Crocetin (Transcrocetin) disodium, extracted from saffron (Crocus sativus L.), acts as an NMDA receptor antagonist with high affinity. Crocetin (Transcrocetin) disodium, extracted from saffron (Crocus sativus L.), acts as an NMDA receptor antagonist with high affinity. Crocetin (Transcrocetin) disodium, extracted from saffron (Crocus sativus L.), acts as an NMDA receptor antagonist with high affinity.

syringin

Eleutheroside B

C17H24O9 (372.142)

Syringin, also known as eleutheroside b or beta-terpineol, is a member of the class of compounds known as phenolic glycosides. Phenolic glycosides are organic compounds containing a phenolic structure attached to a glycosyl moiety. Some examples of phenolic structures include lignans, and flavonoids. Among the sugar units found in natural glycosides are D-glucose, L-Fructose, and L rhamnose. Syringin is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Syringin can be found in caraway, fennel, and lemon, which makes syringin a potential biomarker for the consumption of these food products. Syringin is a natural chemical compound first isolated from the bark of lilac (Syringa vulgaris) by Meillet in 1841. It has since been found to be distributed widely throughout many types of plants. It is also called eleutheroside B, and is found in Eleutherococcus senticosus (Siberian ginseng). It is also found in dandelion coffee . Syringin is a main bioactive phenolic glycoside in Acanthopanax senticosus, with anti-osteoporosis activity. Syringin prevents cardiac hypertrophy induced by pressure overload through the attenuation of autophagy[1][2]. Syringin is a main bioactive phenolic glycoside in Acanthopanax senticosus, with anti-osteoporosis activity. Syringin prevents cardiac hypertrophy induced by pressure overload through the attenuation of autophagy[1][2].

(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[4-[(E)-3-hydroxyprop-1-enyl]-2,6-dimethoxyphenoxy]oxane-3,4,5-triol

NCGC00180873-02!(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[4-[(E)-3-hydroxyprop-1-enyl]-2,6-dimethoxyphenoxy]oxane-3,4,5-triol

C17H24O9 (372.142)

(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[4-[(E)-3-hydroxyprop-1-enyl]-2,6-dimethoxyphenoxy]oxane-3,4,5-triol [IIN-based: Match]

NCGC00180873-02!(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[4-[(E)-3-hydroxyprop-1-enyl]-2,6-dimethoxyphenoxy]oxane-3,4,5-triol [IIN-based: Match]

C17H24O9 (372.142)

syringin_major

C17H24O9 (372.142)

Val-Phe-OH

(S)-2-(3-isopropoxy-4-nitrobenzamido)-3-phenylpropanoic acid

C19H20N2O6 (372.1321)

Phe-Val-OH

(S)-2-(3-(benzyloxy)-4-nitrobenzamido)-4-methylpentanoic acid

C19H20N2O6 (372.1321)

Phe-Leu-OH

(S)-2-(3-(benzyloxy)-4-nitrobenzamido)-5-methylhexanoic acid

C19H20N2O6 (372.1321)

HoPhe-Abu-OH

(S)-2-(4-nitro-3-phenethoxybenzamido)pentanoic acid

C19H20N2O6 (372.1321)

Abu-HoPhe-OH

(S)-2-(3-ethoxy-4-nitrobenzamido)-5-phenylpentanoic acid

C19H20N2O6 (372.1321)

Citrusin E

methyl 3-(3-methoxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)propanoate

C17H24O9 (372.142)

15S-hydroxy-18-bromo-12Z,16,17S-octadecatrienoic acid

(12Z,15S,18S)-15-hydroxy-18-bromo-12,16,17-octadecatrienoic acid

C18H29BrO3 (372.13)

15R-hydroxy-18-bromo-13E,16,17R-octadecatrienoic acid

(13E,15R,18R)-15-hydroxy-18-bromo-13,16,17-octadecatrienoic acid

C18H29BrO3 (372.13)

15S-hydroxy-18S-bromo-12E,16,17-octadecatrienoic acid

(12E,15S,18S)-15-hydroxy-18-bromo-12,16,17-octadecatrienoic acid

C18H29O3Br (372.13)

15R-hydroxy-18R-bromo-13Z,16,17-octadecatrienoic acid

(13Z,15R,18R)-15-hydroxy-18-bromo-13,16,17-octadecatrienoic acid

C18H29O3Br (372.13)

TRIS(TRIMETHYLSILOXY)PHENYLSILANE

C15H32O3Si4 (372.1428)

3-[(2-CHLOROPHENYL)(2-HYDROXYETHYLAMINO)METHYL]-1H-INDOLE-2-CARBOXYLIC ACID ETHYL ESTER

C20H21ClN2O3 (372.1241)

3-ETHYLAMINOPHENOL HEMISULFATE

C16H24N2O6S (372.1355)

2-acetamido-3,4,6-tri-o-acetyl-2-deoxy-beta-d-glucopyranosyl azide

C14H20N4O8 (372.1281)

2,2-[[4-[(6-methoxybenzothiazol-2-yl)azo]phenyl]imino]bisethanol

C18H20N4O3S (372.1256)

4-(Chloromethyl)-5-methyl-1-(triphenylmethyl)-1H-imidazole

C24H21ClN2 (372.1393)

4-(2-Chloroethyl)-1-(triphenylmethyl)-1H-imidazole

C24H21ClN2 (372.1393)

3,5-Pyridinedicarboxylicacid, 2,6-dimethyl-4-(3-nitrophenyl)-, 3,5-diethyl ester

C19H20N2O6 (372.1321)

(1R,4R)-[4-(6-Chloro-2-Methylsulfanyl-pyriMidin-4-ylaMino)-cyclohexyl]-carbaMic acid tert-butyl ester

C16H25ClN4O2S (372.1387)

4-[[3-[2-(3-Chlorophenyl)ethyl]-2-pyridinyl]carbonyl]-1-piperidinecarboxylic Acid

C20H21ClN2O3 (372.1241)

bis(pentamethylcyclopentadienyl)ruthenium

C20H30Ru (372.1391)

1-Dodecyl-4-iodobenzene

C18H29I (372.1314)

3-[4,8-dimethyl-2-oxo-7-(2H-tetrazol-5-ylmethoxy)-1-benzopyran-3-yl]propanoic acid ethyl ester

C18H20N4O5 (372.1434)

4-Pyrimidinecarboxylic acid, 2,6-bis(trimethylsiloxy)-, trimethylsilyl ester

C14H28N2O4Si3 (372.1357)

Glucoside,6-dimethoxyphenyl, D

C17H24O9 (372.142)

1-[(3-methylbutanoyl)phloroglucinyl]-beta-D-glucopyranoside

C17H24O9 (372.142)

A beta-D-glucoside compound having a (3-methylbutanoyl)phloroglucinyl moiety at the anomeric position. Isolated from the whole plant of Indigofera heterantha, it exhibits lipoxygenase inhibitory activity.

2-[(3-methoxyphenoxy)methyl]-7-phenyl-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine

C20H16N6O2 (372.1335)

4-O-beta-D-glucopyranosyl-L-glycero-alpha-D-manno-heptopyranose

C13H24O12 (372.1268)

3,4-dihydro-2H-quinolin-1-yl-[4-(phenylmethyl)-5-thieno[3,2-b]pyrrolyl]methanone

C23H20N2OS (372.1296)

1-[(pentanoyl)-phloroglucinyl]-beta-D-glucopyranoside

C17H24O9 (372.142)

A beta-D-glucoside compound having a (pentanoyl)-phloroglucinyl moiety at the anomeric position. Isolated from the whole plant of Indigofera heterantha, it exhibits lipoxygenase inhibitory activity.

3-[5-(5-methyl-2-thiophenyl)-1,3,4-oxadiazol-2-yl]-N-[2-(3-pyridinyloxy)propyl]propanamide

C18H20N4O3S (372.1256)

6-(2-Chlorophenyl)-3-methyl-2-[4-morpholinyl(oxo)methyl]-1,5,6,7-tetrahydroindol-4-one

C20H21ClN2O3 (372.1241)

N-[1-(1H-benzimidazol-2-yl)ethyl]-3-(dimethylsulfamoyl)benzamide

C18H20N4O3S (372.1256)

N-[3-[[2-(2-fluorophenyl)-4-quinazolinyl]amino]phenyl]acetamide

C22H17FN4O (372.1386)

4-(6-chloro-2-methyl-2,3-dihydro-1,4-benzoxazin-4-yl)-4-oxo-N-(phenylmethyl)butanamide

C20H21ClN2O3 (372.1241)

N-[(E)-[5-(4-Methyl-3-nitrophenyl)furan-2-yl]methylideneamino]-2-morpholin-4-ylacetamide

C18H20N4O5 (372.1434)

2-[2-(1-Azabicyclo[2.2.2]octan-3-ylidene)-2-fluoroethoxy]-9H-carbazole;hydrochloride

C21H22ClFN2O (372.1405)

6-O-D-glycero-alpha-D-manno-heptopyranosyl-beta-D-glucopyranose

C13H24O12 (372.1268)

1-Butyl-N-(5-ethyl-1,3,4-thiadiazol-2-yl)-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxamide

C18H20N4O3S (372.1256)

(1R,5S)-6-(3-fluorophenyl)sulfonyl-7-[4-[(E)-prop-1-enyl]phenyl]-3,6-diazabicyclo[3.1.1]heptane

C20H21FN2O2S (372.1308)

(1S,5R)-3-(2-fluorophenyl)sulfonyl-7-[4-[(E)-prop-1-enyl]phenyl]-3,6-diazabicyclo[3.1.1]heptane

C20H21FN2O2S (372.1308)

6-methoxy-1-(3-methoxyprop-1-ynyl)-2-[(5-nitro-2-furanyl)methyl]-3,4-dihydro-1H-isoquinolin-7-ol

C19H20N2O6 (372.1321)

3,4,5-Trihydroxy-6-[4-(3-hydroxybutyl)-2-methoxyphenoxy]oxane-2-carboxylic acid

C17H24O9 (372.142)

2-[[(2R)-2-(4-carboxybutanoyloxy)-3-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C13H27NO9P+ (372.1423)

2-(Hydroxymethyl)-6-[4-(3-hydroxyprop-1-enyl)-2,6-dimethoxyphenoxy]oxane-3,4,5-triol

C17H24O9 (372.142)

ST 21:6;O;S

C21H24O4S (372.1395)

YK-3-237

C19H21BO7 (372.138)

YK-3-237, a SIRT1 activator, targets mutant p53. YK-3-237 inhibits the proliferation of triple-negative breast cancer cells[1].

1-(2,4-dihydroxy-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-3-methylbutan-1-one

C17H24O9 (372.142)

(1r,3r,4r,5r,6r,7r,10r,13r)-7-chloro-6-hydroxy-10-methoxy-3,4,13-trimethyl-11,14-dioxatetracyclo[8.4.0.0¹,¹³.0³,⁸]tetradec-8-en-5-yl acetate

C18H25ClO6 (372.134)

1-(3,5-dimethoxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)propan-1-one

C17H24O9 (372.142)

6'-hydroxy-1-methoxy-2-oxo-10'-oxa-5'-azaspiro[indole-3,2'-tricyclo[5.3.1.0⁴,⁸]undecan]-5'-en-11'-yl acetate

C19H20N2O6 (372.1321)

(2s,3r,4s,5r,6s)-2-(hydroxymethyl)-6-{4-[(1e)-3-hydroxyprop-1-en-1-yl]-2,6-dimethoxyphenoxy}oxane-3,4,5-triol

C17H24O9 (372.142)

(2r)-1-(2,4-dihydroxy-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-2-methylbutan-1-one

C17H24O9 (372.142)

1-[2-hydroxy-6-(methoxymethyl)-3-methyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl]ethanone

C17H24O9 (372.142)

1-[(pentanoyl)phloroglucinyl]-β-d-glucopyrano-side

C17H24O9 (372.142)

{"Ingredient_id": "HBIN002959","Ingredient_name": "1-[(pentanoyl)phloroglucinyl]-\u03b2-d-glucopyrano-side","Alias": "NA","Ingredient_formula": "C17H24O9","Ingredient_Smile": "CCCCC(=O)C1=C(C=C(C=C1OC2C(C(C(C(O2)CO)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "16873","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3,5-dimethoxy-4-glucosyloxy-phenyl-propenyl alcohol

C17H24O9 (372.142)

{"Ingredient_id": "HBIN007640","Ingredient_name": "3,5-dimethoxy-4-glucosyloxy-phenyl-propenyl alcohol","Alias": "NA","Ingredient_formula": "C17H24O9","Ingredient_Smile": "COC1=CC(=C(C=C1)CCC(=O)OC)OC2C(C(C(C(O2)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25854","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}